Millions of Americans have type 2 diabetes that requires them to take medication. Two of the type 2 diabetes medications on the market, Onglyza and Kombiglyze XR, have been linked with an increased risk of heart failure. One study found that the use of Onglyza was associated with a 27 percent increased rate of hospitalization for heart failure. Numerous lawsuits have been filed across the country by patients who have suffered life-threatening side effects from using the defective drugs.
FREE ONGLYZA CASE REVIEW 1-800-587-1889
Dangerous Onglyza Side Effects Hidden from the Public
Onglyza lawsuits allege various causes of action, including but not limited to:
- Failing to conduct pre-market trials and studies to determine the impact on the risk of cardiovascular diseases;
- Marketing drugs with the knowledge that these drugs carried an increased risk of heart failure;
- Negligently and fraudulently marketing the drugs; and,
- Failing to adequately warn health care providers and patients of the potential side effects associated with using Onglyza or Kombiglyze XR.
Plaintiffs are seeking compensation for damages including medical expenses, loss of income, emotional and physical trauma, wrongful death, reduced earning potential, loss of consortium, and punitive damages. It is important to work with experienced Onglyza and Kombiglyze XR attorneys to seek the maximum compensation for damages allowed by law.
IF YOU HAVE BEEN DIAGNOSED WITH HEART FAILURE AFTER TAKING ONGLYZA AND KOMBIGLYZE XR
CALL 1-800-587-1889 FOR A FREE CASE EVALUATION.
Onglyza and Kombiglyze XR Could Cause Serious Heart Risks and Cancer
Bristol-Myers Squibb and AstraZeneca have been named in numerous lawsuits alleging product liability claims related to the life-altering and deadly side effects of the type 2 diabetes drugs Onglyza and Kombiglyze XR. These diabetes drugs have been associated with an increased risk of catastrophic cardiovascular damage and heart failure. The FDA has issued a Drug Safety Communication for type 2 diabetes medications containing alogliptin and saxagliptin, including Onglyza and Kombiglyze XR. Kombiglyze XR has also been linked to an increased risk of pancreatitis and pancreatic cancer.
After reviewing clinical trial data, the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee recommended a label update to warn consumers and medical professionals of the potential for an increased risk of heart failure by a vote of 14 to 1. The one person that voted against the label update recommended that the products be removed from the market. The lawsuits allege that the drugs’ manufacturers failed to update the warnings or remove the dangerous drugs from the market, thereby putting profits above patients’ safety, health, and welfare.
TIME IS LIMITED TO FILE A CLAIM — CALL NOW TO SPEAK WITH AN ATTORNEY
We are Onglyza Attorneys Helping Patients Seek Justice for Damages Caused by Defective Drugs
Protect Your Rights! Contact Us Now!
Contact Attorney Fred Olinde of The Olinde Firm for a free confidential lawsuit consultation with one of our pharmaceutical litigation attorneys. Call (504) 587-1440 or 1-800-587-1889 to request your free case evaluation with a nationwide Onglyza lawsuit attorney.